Despite vaccine shortages, many younger people in New York City accessed vaccines ahead of schedule, particularly in high-income areas, according to new research at Columbia
Weill Cornell Medicine scientists have developed an innovative human neuron model that robustly simulates the spread of tau protein aggregates in the brain-;a process that
In a small, investigator-initiated phase 2 study by Dana-Farber Cancer Institute investigators, a novel combination of an antibody-drug conjugate and an immune checkpoint inhibitor showed
The Centers for Disease Control and Prevention urged medical practitioners on Friday to be on the lookout for people who might have contracted H5N1 bird
Daily and lifetime exposure to stress may cause wear and tear on the stress responses of Black Americans, blunting their biological stress response, a new
A research group centered at the University of California San Diego School of Medicine has drilled deep into a dataset of over 3 million individuals
Diagnosing infectious conditions can be challenging. Diagnosis is especially challenging for uncommon and emerging infectious diseases for which there’s limited clinical experience.
The Department of Defense awarded a little more than $1.9 million to a multidisciplinary team of researchers at the University of Arkansas and University of
The protein content of the diet during pregnancy can affect the face of the offspring. This is shown in animal studies, and the underlying mechanism
VANCOUVER, BC / ACCESSWIRE / April 3, 2024 / Clairvoyant Therapeutics Inc. (www.clairvoyantrx.com), the private clinical-stage pharmaceutical company developing psilocybin treatment for alcohol use disorder (AUD),